Skip to main content

IRulya Therapeutics Inc 10-K for FY2025

IRulya Therapeutics Inc. (IRLA)

10-K 2026-04-10 For: 2025-12-31
View Original
Added on April 12, 2026

About this 10-K

IRulya Therapeutics Inc filed this 10-K on April 10, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$83.98M
compared with a net loss of $56.83M a year earlier
Diluted EPS
-$1.68
compared with -$1.31 a year earlier